ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+9.87%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$299M
AUM Growth
-$469K
(-0.16%)
Cap. Flow
-$28.5M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
92
New
15
Increased
30
Reduced
32
Closed
15
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$10.1M |
| 2 |
Encompass Health
EHC
|
$8.46M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$6.36M |
| 4 |
Biogen
BIIB
|
$5.49M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$4.67M |
Top Sells
| 1 |
Globus Medical
GMED
|
$11.4M |
| 2 |
Thermo Fisher Scientific
TMO
|
$11.3M |
| 3 |
Merck
MRK
|
$10.2M |
| 4 |
Becton Dickinson
BDX
|
$8.92M |
| 5 |
STJ
St Jude Medical
STJ
|
$7.33M |
Sector Composition
| 1 | Healthcare | 89.39% |
| 2 | Financials | 3.11% |
| 3 | Technology | 0.63% |
| 4 | Industrials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cardinal Health
CAH
$35.6B
| $1.56M | 0.52% |
17,500
+1,800
| +11% | +$161K |
|
|
BDSI
52
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.33M | 0.45% |
278,380
+254,880
| +1,085% | +$1.22M |
|
|
53
Globus Medical
GMED
$8.01B
| $1.24M | 0.42% |
44,629
-409,100
| -90% | -$11.4M |
|
|
HZNP
54
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.21M | 0.41% |
55,940
-64,760
| -54% | -$1.4M |
|
55
Humana
HUM
$37.7B
| $1.2M | 0.4% |
6,698
-15,100
| -69% | -$2.7M |
|
|
RAD
56
DELISTED
Rite Aid Corporation
RAD
| $1.15M | 0.39% |
7,358
+5,383
| +273% | +$844K |
|
|
NSTG
57
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.12M | 0.38% |
+76,311
| New | +$1.12M |
|
|
HMSY
58
DELISTED
HMS Holdings Corp.
HMSY
| $1.05M | 0.35% |
85,163
-294,700
| -78% | -$3.64M |
|
|
XENT
59
DELISTED
Intersect ENT, Inc
XENT
| $900K | 0.3% |
+40,000
| New | +$900K |
|
60
Bausch Health
BHC
$2.65B
| $793K | 0.27% |
7,800
-3,700
| -32% | -$376K |
|
61
Elevance Health
ELV
$70.1B
| $762K | 0.25% |
+5,467
| New | +$762K |
|
62
Charles River Laboratories
CRL
$7.94B
| $690K | 0.23% |
8,588
+2,088
| +32% | +$168K |
|
63
DaVita
DVA
$9.74B
| $661K | 0.22% |
9,489
-10,611
| -53% | -$739K |
|
|
TVTY
64
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $659K | 0.22% |
51,211
-23,689
| -32% | -$305K |
|
|
SSRG
65
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $629K | 0.21% |
68,333
-56,471
| -45% | -$520K |
|
66
Incyte
INCY
$16.7B
| $618K | 0.21% |
+5,700
| New | +$618K |
|
67
Johnson & Johnson
JNJ
$428B
| $596K | 0.2% |
5,800
-54,100
| -90% | -$5.56M |
|
68
Illumina
ILMN
$15.2B
| $557K | 0.19% |
+2,981
| New | +$557K |
|
|
MDVN
69
DELISTED
MEDIVATION, INC.
MDVN
| $556K | 0.19% |
+11,500
| New | +$556K |
|
70
PTC Therapeutics
PTCT
$4.48B
| $480K | 0.16% |
14,800
-8,200
| -36% | -$266K |
|
|
DERM
71
DELISTED
Dermira, Inc.
DERM
| $456K | 0.15% |
+13,188
| New | +$456K |
|
|
OCRX
72
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $428K | 0.14% |
137,093
-40,028
| -23% | -$125K |
|
73
Regeneron Pharmaceuticals
REGN
$59.7B
| $405K | 0.14% |
746
-1,654
| -69% | -$898K |
|
|
WCG
74
DELISTED
Wellcare Health Plans, Inc.
WCG
| $360K | 0.12% |
+4,604
| New | +$360K |
|
75
Acadia Pharmaceuticals
ACAD
$4.3B
| $357K | 0.12% |
10,010
+310
| +3% | +$11.1K |
|